Merz: Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke (PLUS)

Summary

To test the safety and efficacy of NT 201 (Xeomin) for treating lower limb spasticity caused by stroke or traumatic brain injury in adult subjects, followed by an open label extension with or without combined upper limb treatment

Primary Investigator: Nicholas Ketchum, MD

Status: Currently Enrolling

Share This: